Ayano M, Tsubouchi K, Suzuki K, Kimoto Y, et al. Comparing the safety and efficacy of nintedanib starting dose in patients with connective tissue disease-associated interstitial lung diseases. Scand J Rheumatol 2024;53:255-262.
PMID: 38563202